表紙
市場調查報告書

全球體外診斷藥物(IVD)市場:2019評論和數據

IVDMARKETREACH: 2019 Global IVD Market Review and Data

出版商 EAC (Enterprise Analysis Corporation) 商品編碼 968801
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
如有價格方面的疑問請按下「詢問」鍵來信查詢
全球體外診斷藥物(IVD)市場:2019評論和數據 IVDMARKETREACH: 2019 Global IVD Market Review and Data
出版日期: 2020年11月05日內容資訊: 英文
簡介

本報告調查了全球體外診斷(IVD)市場,並詳細分析了140家關聯公司的年收入,詳細分析了北美,歐洲/中東/非洲各個領域的主要公司。提供有關日本,亞太地區和拉丁美洲每個地區的市場分析等信息。

報告摘要

  • 區域市場
    • 產品領域:WBGM,中央實驗室免疫學,臨床化學,POC/POL,臨床化學,臨床微生物學,血液學,解剖病理學,凝血,中央實驗室急診和重症監護,血液篩查免疫學,免疫血Gaku,血液篩查分子測試,中心實驗室尿液測試,臨床流式細胞儀等
    • 地區:北美,歐洲/中東/非洲,日本,亞太地區,拉丁美洲
    • 5年增長率:區域和部門增長矩陣
  • 在PowerPoint報告中附加了將以下內容概述的電子錶格
    • 字段定義
    • 適用於部門和區域收入分配的先決條件
    • 匯總各種數據的圖
    • 每個領域的趨勢和發展評論
    • 關聯公司亮點
  • 按領域劃分的公司:基於各領域收入的主要公司
  • 分子:傳染病,基因組學,樣品製備/其他
  • POC/POL:主要公司和領域的利潤
    • 心臟,HbA1c,凝血,血液學,化學,免疫測定,重症監護,尿液檢查,分子等。

目錄

體外診斷市場:

  • 在每個產品領域中表現最好的公司
  • 每個地區每個產品領域的分析和市場份額
  • 每個產品領域的分析以及每個地區的5年增長率

分子市場:

  • 每個領域的主要公司

POC/POL市場:

  • 每個領域的主要公司
  • 5年增長率
目錄

2019 IVD market data derived from an in-depth analysis of annual revenues of the largest 140 IVD companies. Custom data subsets are available on request.

The full data set includes the following:

  • Disciplines by Region: Includes worldwide revenues for 16 disciplines by 5 regions with five year growth rates.
    • 16 disciplines include: WBGM, Central Lab Immuno, Clinical Chemistry, POC/POL, Clinical Molecular, Clinical Microbiology, Hematology, Anatomic Pathology, Coagulation, Central Lab Critical Care, Blood Screening Immuno, Immuno-Hematology, Blood Screening Molecular, Central Lab Urinalysis, Clinical Flow Cytometry and Other Products.
    • Regions include: North America, EMEA, Japan, Asia Pacific and Latin America.
    • 5 Year growth rates; matrix to provide growth by discipline by region.
  • A PowerPoint Report will accompany the spreadsheet outlining the following:
    • Discipline definitions
    • Assumptions applied to distributing revenues across disciplines and regions
    • Charts depicting available data
    • Selected commentary on trends and developments in each discipline
    • Company highlights
  • Companies by Disciplines: The top performing companies by revenue, operating within a discipline. Each category has an "other" category which will list the companies included.
  • Molecular: Worldwide revenues broken down across the top performing companies and by infectious diseases, genomics and sample preparation/other.
  • POC/POL: Worldwide revenues broken down across the top performing companies and 8 different disciplines.
    • 8 disciplines include: Cardiac, HbA1c, Coagulation, Hematology, Chemistry, Immunoassay, Critical Care, Urinalysis, Molecular and Other Products.
  • 5 Year growth rates; matrix to provide growth by discipline and for top 10 companies within each discipline.

Note: Subsets of the data (e.g., certain disciplines) or custom analysis are available upon request.

Table of Contents

The data will be delivered in 3 separate PDF files. The data reflects the following information:

IVD market:

  • Top performing companies across 16 disciplines
  • 16 disciplines across 5 regions with regional market share
  • 16 disciplines with 5 year growth rates by region

Molecular market:

  • Top performing companies across 3 segments

POC/POL market:

  • Top performing companies across 10 disciplines
  • 10 disciplines with 5 year growth rates